The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Citronowicz Moshe since 2005.
This trader's CIK number is 1280851.
At the time of last reporting, Citronowicz Moshe was the Sr. V.P. of Operations of Apyx Medical Corp. (stock ticker symbol APYX).
Also see all insider trading activities at Apyx Medical Corp.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | APYX | 0 | $0 | 0 | $0 | 30,000 | $76,200 |
| 2015 | APYX | 20,000 | $36,780 | 0 | $0 | 0 | $0 |
| 2009 | APYX | 0 | $0 | 60,000 | $399,494 | 0 | $0 |
| 2008 | APYX | 0 | $0 | 40,000 | $288,468 | 0 | $0 |
| 2007 | APYX | 0 | $0 | 20,000 | $182,364 | 0 | $0 |
| 2005 | APYX | 0 | $0 | 10,000 | $29,600 | 0 | $0 |
| 2005 | APYX | 0 | $0 | 15,000 | $42,900 | 15,000 | $16,875 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-07-11 | APYX | Option Ex | 30,000 | 2.54 | 76,200 |
| 2015-12-21 | BVX | Buy | 20,000 | 1.84 | 36,780 |
| 2009-05-12 | BVX | Sale | 13,500 | 7.45 | 100,575 |
| 2009-04-15 | BVX | Sale | 6,500 | 7.06 | 45,890 |
| 2009-04-08 | BVX | Sale | 19,000 | 6.31 | 119,889 |
| 2009-04-09 | BVX | Sale | 21,000 | 6.34 | 133,140 |
| 2008-09-19 | BVX | Sale | 21,700 | 7.23 | 156,891 |
| 2008-09-17 | BVX | Sale | 18,300 | 7.19 | 131,577 |
| 2007-02-13 | BVX | Sale | 10,491 | 9.12 | 95,730 |
| 2007-02-08 | BVX | Sale | 6,200 | 9.12 | 56,519 |
| 2007-02-09 | BVX | Sale | 3,309 | 9.10 | 30,115 |
| 2005-01-06 | BVX | Sale | 10,000 | 2.96 | 29,600 |
| 2005-12-05 | BVX | Option Ex | 15,000 | 1.12 | 16,875 |
| 2005-12-21 | BVX | Sale | 15,000 | 2.86 | 42,900 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Citronowicz Moshe (Sr. V.P. of Operations of Apyx Medical Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.